Musaffa Logo
Roche Holding AG ROGH.VI

Last Updated: Jul 21, 12:00 AM·WBAG

ROGH.VI Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Roche Holding AG is classified as halal.

HALAL

Report Source: 2025 Annual Report

Roche Holding AG

Roche Holding AG. Stock Analysis ROGH.VI

Austria Health Care Mega Cap Report:
Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!